WESTLIFE.NS(WESTLIFE.NS)
WESTLIFE.NS
No analyst ratings available
No analyst price targets available for WESTLIFE.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $29.38B | $33.30B | $37.62B | $45.92B | $50.79B |
| Low | $28.63B | $32.30B | $36.56B | $44.64B | $49.37B |
| High | $30.46B | $35.25B | $39.43B | $48.13B | $53.24B |
| EBITDA Avg | $4.49B | $5.08B | $5.74B | $7.01B | $7.75B |
| Low | $4.37B | $4.93B | $5.58B | $6.81B | $7.54B |
| High | $4.65B | $5.38B | $6.02B | $7.35B | $8.13B |
| EBIT Avg | $2.13B | $2.42B | $2.73B | $3.33B | $3.68B |
| Low | $2.08B | $2.34B | $2.65B | $3.24B | $3.58B |
| High | $2.21B | $2.56B | $2.86B | $3.49B | $3.86B |
| Net Income Avg | $217M | $700M | $1.59B | — | — |
| Low | $22M | $259M | $1.53B | — | — |
| High | $448M | $1.16B | $1.69B | — | — |
| EPS Avg | $1.39 | $4.48 | $10.19 | — | — |
| Low | $0.14 | $1.66 | $9.82 | — | — |
| High | $2.87 | $7.41 | $10.82 | — | — |
| Analysts (Rev / EPS) | 19 / 17 | 17 / 17 | 15 / 14 | 8 / 7 | 7 / 8 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $7.20B | $7.59B | $7.40B |
| Low | $7.07B | $7.45B | $7.26B |
| High | $7.33B | $7.73B | $7.53B |
| EBITDA Avg | $1.10B | $1.16B | $1.13B |
| Low | $1.08B | $1.14B | $1.11B |
| High | $1.12B | $1.18B | $1.15B |
| EBIT Avg | $522M | $551M | $537M |
| Low | $513M | $541M | $527M |
| High | $532M | $561M | $546M |
| Net Income Avg | $-51M | $169M | $313M |
| Low | $-53M | $165M | $305M |
| High | $-50M | $173M | $320M |
| EPS Avg | $-0.33 | $1.06 | $1.98 |
| Low | $-0.33 | $1.04 | $1.93 |
| High | $-0.32 | $1.09 | $2.02 |
| Analysts (Rev / EPS) | 2 / 1 | 1 / 1 | 1 / 1 |